Cargando…
Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
Coronavirus disease 2019 (COVID-19) patients can develop interstitial pneumonia, which, in turn, can evolve into acute respiratory distress syndrome (ARDS). This is accompanied by an inflammatory cytokine storm. severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has proteins capable o...
Autores principales: | Falcone, Carmela, Caracciolo, Massimo, Correale, Pierpaolo, Macheda, Sebastiano, Vadalà, Eugenio Giuseppe, La Scala, Stefano, Tescione, Marco, Danieli, Roberta, Ferrarelli, Anna, Tarsitano, Maria Grazia, Romano, Lorenzo, De Lorenzo, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564484/ https://www.ncbi.nlm.nih.gov/pubmed/32967358 http://dx.doi.org/10.3390/jcm9093045 |
Ejemplares similares
-
Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients
por: Caracciolo, Massimo, et al.
Publicado: (2021) -
Fat mass affects nutritional status of ICU COVID-19 patients
por: De Lorenzo, Antonino, et al.
Publicado: (2020) -
Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity
por: Gualtieri, Paola, et al.
Publicado: (2020) -
Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
por: Caracciolo, Massimo, et al.
Publicado: (2020) -
Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia
por: Correale, Pierpaolo, et al.
Publicado: (2020)